Kymera Therapeutics
KYMR
#2602
Rank
โ‚น601.80 B
Marketcap
โ‚น7,371
Share price
-2.52%
Change (1 day)
184.82%
Change (1 year)

Revenue for Kymera Therapeutics (KYMR)

Revenue in 2025 (TTM): โ‚น3.37 Billion

According to Kymera Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น3.69 Billion. a decrease over the revenue in the year 2024 that were of โ‚น4.03 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Kymera Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น3.51 B-12.83%
2024 โ‚น4.03 B-38.28%
2023 โ‚น6.54 B68.85%
2022 โ‚น3.87 B-28.52%
2021 โ‚น5.42 B117.79%
2020 โ‚น2.48 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA